Geode Capital Management’s 10x Genomics TXG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$61.7M Buy
2,904,228
+114,444
+4% +$2.29M ﹤0.01% 1384
2025
Q4
$45.5M Buy
2,789,784
+78,541
+3% +$1.19M ﹤0.01% 1543
2025
Q3
$31.7M Buy
2,711,243
+60,424
+2% +$788K ﹤0.01% 1759
2025
Q2
$30.7M Buy
2,650,819
+773,203
+41% +$7.05M ﹤0.01% 1711
2025
Q1
$16.4M Buy
1,877,616
+62,793
+3% +$792K ﹤0.01% 1999
2024
Q4
$26.1M Sell
1,814,823
-887
-0% -$14K ﹤0.01% 1819
2024
Q3
$41M Buy
1,815,710
+42,777
+2% +$884K ﹤0.01% 1551
2024
Q2
$34.5M Buy
1,772,933
+129,780
+8% +$3.4M ﹤0.01% 1611
2024
Q1
$61.7M Buy
1,643,153
+55,338
+3% +$2.43M 0.01% 1214
2023
Q4
$88.9M Buy
1,587,815
+68,771
+5% +$2.99M 0.01% 939
2023
Q3
$62.7M Buy
1,519,044
+84,243
+6% +$4.38M 0.01% 1073
2023
Q2
$80.1M Buy
1,434,801
+68,905
+5% +$3.73M 0.01% 933
2023
Q1
$76.2M Buy
1,365,896
+44,662
+3% +$2.09M 0.01% 907
2022
Q4
$48.1M Buy
1,321,234
+63,324
+5% +$2.07M 0.01% 1171
2022
Q3
$35.8M Buy
1,257,910
+38,393
+3% +$1.46M 0.01% 1329
2022
Q2
$55.2M Buy
1,219,517
+31,078
+3% +$1.61M 0.01% 1041
2022
Q1
$90.3M Buy
1,188,439
+28,984
+2% +$2.54M 0.01% 833
2021
Q4
$173M Buy
1,159,455
+30,714
+3% +$4.7M 0.02% 586
2021
Q3
$164M Buy
1,128,741
+119,254
+12% +$20.5M 0.02% 583
2021
Q2
$197M Buy
1,009,487
+107,662
+12% +$19.5M 0.03% 538
2021
Q1
$163M Buy
901,825
+113,719
+14% +$19.6M 0.02% 568
2020
Q4
$111M Buy
788,106
+102,357
+15% +$14.9M 0.02% 644
2020
Q3
$85.5M Buy
685,749
+381,564
+125% +$40.1M 0.02% 663
2020
Q2
$27.2M Buy
304,185
+198,559
+188% +$15.5M 0.01% 1277
2020
Q1
$6.58M Buy
105,626
+15,754
+18% +$1.23M ﹤0.01% 1987
2019
Q4
$6.85M Buy
+89,872
New +$5.4M ﹤0.01% 2267

Other funds holding TXG